These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6302117)

  • 1. Photoaffinity labeling of the N-formyl peptide receptor of human polymorphonuclear leukocytes.
    Painter RG; Schmitt M; Jesaitis AJ; Sklar LA; Preissner K; Cochrane CG
    J Cell Biochem; 1982; 20(2):203-14. PubMed ID: 6302117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
    Gardner JP; Melnick DA; Malech HL
    J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand/receptor internalization: a spectroscopic analysis and a comparison of ligand binding, cellular response, and internalization by human neutrophils.
    Sklar LA; Jesaitis AJ; Painter RG; Cochrane CG
    J Cell Biochem; 1982; 20(2):193-202. PubMed ID: 6302116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils.
    Klotz KN; Krotec KL; Gripentrog J; Jesaitis AJ
    J Immunol; 1994 Jan; 152(2):801-10. PubMed ID: 8283053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional integrity of cytokineplasts: specific chemotactic and capping responses.
    Dyett DE; Malawista SE; Van Blaricom G; Melnick DA; Malech HL
    J Immunol; 1985 Sep; 135(3):2090-4. PubMed ID: 2991379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
    Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
    J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of neutrophil N-formyl peptide receptors by using antibodies and fluorescent peptides.
    Loitto VM; Rasmusson B; Magnusson KE
    J Leukoc Biol; 2001 May; 69(5):762-71. PubMed ID: 11358985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent affinity labeling of the formyl peptide chemotactic receptor.
    Niedel J; Davis J; Cuatrecasas P
    J Biol Chem; 1980 Aug; 255(15):7063-6. PubMed ID: 7391068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional molecular complexes of human N-formyl chemoattractant receptors and actin.
    Jesaitis AJ; Erickson RW; Klotz KN; Bommakanti RK; Siemsen DW
    J Immunol; 1993 Nov; 151(10):5653-65. PubMed ID: 8228254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-formylpeptide-receptor dynamics, cytoskeletal activation, and intracellular calcium response in human neutrophil cytoplasts.
    Omann GM; Swann WN; Oades ZG; Parkos CA; Jesaitis AJ; Sklar LA
    J Immunol; 1987 Nov; 139(10):3447-55. PubMed ID: 2824606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral segregation of neutrophil chemotactic receptors into actin- and fodrin-rich plasma membrane microdomains depleted in guanyl nucleotide regulatory proteins.
    Jesaitis AJ; Bokoch GM; Tolley JO; Allen RA
    J Cell Biol; 1988 Sep; 107(3):921-8. PubMed ID: 3138250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-cytoskeleton interactions and the regulation of chemotactic peptide-induced activation of human granulocytes: the effects of dihydrocytochalasin B.
    Jesaitis AJ; Tolley JO; Painter RG; Sklar LA; Cochrane CG
    J Cell Biochem; 1985; 27(3):241-53. PubMed ID: 3838753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
    Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
    Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formyl peptide chemotactic receptor. Evidence for an active proteolytic fragment.
    Dolmatch B; Niedel J
    J Biol Chem; 1983 Jun; 258(12):7570-7. PubMed ID: 6305946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of binding properties and structure of NGF receptor on PC12 pheochromocytoma and A875 melanoma cells.
    Buxser SE; Watson L; Johnson GL
    J Cell Biochem; 1983; 22(4):219-33. PubMed ID: 6323498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Becker KM; Feltner DE; Brown CS; Ward PA; Nairn R
    Biochemistry; 1985 Apr; 24(9):2227-36. PubMed ID: 3995012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.